Q1 FY27 snapshot
Announcement Date29-Jul-26
Revenue (Top Line)₹876 Cr
Net Profit (Bottom Line)₹142 Cr
Earnings Per Share (EPS)₹10.27
Expenses₹733 Cr
Net profit margin (calculated)16.2%
Eris Lifesciences Ltd. (ERIS) Quarterly Results: Q1 FY27
Quick answer: Eris Lifesciences Ltd. (NSE: ERIS) reported Q1 FY27 revenue of ₹876 Cr and net profit of ₹142 Cr, with earnings per share (EPS) of ₹10.27, announced on 29-Jul-26.
That works out to a net profit margin of about 16.2% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Eris Lifesciences Ltd.'s Q1 FY27 results
Revenue of ₹876 Cr is what Eris Lifesciences Ltd. earned before costs. Net profit of ₹142 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 16.2%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Eris Lifesciences Ltd. results FAQs
What were Eris Lifesciences Ltd.'s Q1 FY27 results?
Eris Lifesciences Ltd. (NSE: ERIS) reported Q1 FY27 revenue of ₹876 Cr and net profit of ₹142 Cr, with earnings per share (EPS) of ₹10.27, announced on 29-Jul-26.
What is Eris Lifesciences Ltd.'s EPS for Q1 FY27?
Eris Lifesciences Ltd.'s earnings per share for Q1 FY27 was ₹10.27. EPS is net profit divided by the number of outstanding shares.
When did Eris Lifesciences Ltd. announce its Q1 FY27 results?
Eris Lifesciences Ltd. announced its Q1 FY27 results on 29-Jul-26.
What is Eris Lifesciences Ltd.'s net profit margin?
On the reported figures, Eris Lifesciences Ltd.'s Q1 FY27 net profit margin is about 16.2% (net profit ÷ revenue).